Mordechai Yigla
- Microbiology top 2%
-
- Pulmonary Hypertension Research and Treatments 16
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 11
- Chronic Obstructive Pulmonary Disease (COPD) Research 9
- Tracheal and airway disorders 6
- Genetics top 5%
- Vascular Anomalies and Treatments 7
- Nephrology top 5%
-
- Asthma and respiratory diseases 10
-
- Pneumocystis jirovecii pneumonia detection and treatment 6
- Pneumonia and Respiratory Infections 6
- Co-authors
- Shimon A. ReisnerFarid NakhoulOren FruchterZaid AbassiNaveh TovEmília HardakAnna SolomonovAlexandra Balbir‐Gurman
- Journals
- The Journal of Clinical Endocrinology & Metabolism (1 paper)Kidney International (2 papers)CHEST Journal (5 papers)
- Partner nations
- IsraelUnited StatesSwitzerland
In The Last Decade
Mordechai Yigla
69 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 109
- Microbiology 54
- Pulmonary and Respiratory Medicine 1.5k
- Genetics 268
- Cardiology and Cardiovascular Medicine 562
- Nephrology 175
Countries citing papers authored by Mordechai Yigla
This map shows the geographic impact of Mordechai Yigla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mordechai Yigla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mordechai Yigla more than expected).
Fields of papers citing papers by Mordechai Yigla
This network shows the impact of papers produced by Mordechai Yigla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mordechai Yigla. The network helps show where Mordechai Yigla may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mordechai Yigla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 10 | |
| 2 | 2014 | 48 | |
| 3 | 2011 | 22 | |
| 4 | 2011 | 13 | |
| 5 | 2011 | 50 | |
| 6 | 2010 | 5 | |
| 7 | 2010 | 4 | |
| 8 | 2009 | 105 | |
| 9 | 2009 | 9 | |
| 10 | 2008 | 9 | |
| 11 | 2008 | 5 | |
| 12 | 2006 | 84 | |
| 13 | 2006 | 78 | |
| 14 | 2004 | 52 | |
| 15 | 2002 | 46 | |
| 16 | 2001 | 10 | |
| 17 | Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA 134a pressurized metered dose inhaler to patients with moderate to severe asthma. International study group. | 2000 | 15 |
| 18 | 2000 | 11 | |
| 19 | 2000 | 29 | |
| 20 | 1997 | 1 |
About Mordechai Yigla
Mordechai Yigla is a scholar working on Pulmonary and Respiratory Medicine, Microbiology and Genetics, having authored 71 papers that have together received 2.2k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (16 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers), Asthma and respiratory diseases (10 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers), Vascular Anomalies and Treatments (7 papers), Pneumocystis jirovecii pneumonia detection and treatment (6 papers), Tracheal and airway disorders (6 papers) and Pneumonia and Respiratory Infections (6 papers). The work is most often cited by research in Microbiology (54 citations), Pulmonary and Respiratory Medicine (1.5k citations) and Genetics (268 citations). Mordechai Yigla has collaborated with scholars based in Israel, United States and Switzerland. Frequent co-authors include Shimon A. Reisner, Farid Nakhoul, Oren Fruchter, Zaid Abassi, Naveh Tov, Emília Hardak, Anna Solomonov, Alexandra Balbir‐Gurman, Ilana Oren and Yolanda Braun‐Moscovici. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Kidney International and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.